Brief: Bellus Health provides update on pipeline
21/12/2016 12:00
Dec 21 (Reuters) - Bellus Health Inc BLU.TO
* Bellus Health provides update on pipeline
* Auven Therapeutics has decided to terminate Kiacta program
for treatment of AA Amyloidosis
* Continues to explore opportunities in order to expand its
pipeline, including through acquisitions and/or in-licensing
Source text for Eikon: urn:newsml:reuters.com:*:nCNWVBNv5a
Further company coverage: BLU.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln